Literature DB >> 32719503

Aspirin and ibuprofen could lower risk of LRRK2 Parkinson disease.

Ian Fyfe1.   

Abstract

Entities:  

Year:  2020        PMID： 32719503     DOI： 10.1038/s41582-020-0394-7

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  1 in total

1.  Nonsteroidal Anti-inflammatory Use and LRRK2 Parkinson's Disease Penetrance.

Authors:  Marta San Luciano; Caroline M Tanner; Cheryl Meng; Connie Marras; Samuel M Goldman; Anthony E Lang; Eduardo Tolosa; Birgitt Schüle; J William Langston; Alexis Brice; Jean-Christophe Corvol; Stefano Goldwurm; Christine Klein; Simone Brockman; Daniela Berg; Kathrin Brockmann; Joachim J Ferreira; Meriem Tazir; George D Mellick; Carolyn M Sue; Kazuko Hasegawa; Eng King Tan; Susan Bressman; Rachel Saunders-Pullman
Journal:  Mov Disord       Date:  2020-07-14       Impact factor: 10.338
  1 in total
  5 in total

Review 1.  Therapeutic Strategies for Immune Transformation in Parkinson's Disease.

Authors:  Maamoon Saleh; Milica Markovic; Katherine E Olson; Howard E Gendelman; R Lee Mosley
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.520

Review 2.  COVID-19 and Parkinson's Disease: Possible Links in Pathology and Therapeutics.

Authors:  Shubhangini Tiwari; Neelam Yadav; Sarika Singh
Journal:  Neurotox Res       Date:  2022-07-13       Impact factor: 3.978

3.  Evidence of Inflammation in Parkinson's Disease and Its Contribution to Synucleinopathy.

Authors:  Thuy Thi Lai; Yun Joong Kim; Hyeo-Il Ma; Young Eun Kim
Journal:  J Mov Disord       Date:  2021-11-03

Review 4.  Update to the Treatment of Parkinson's Disease Based on the Gut-Brain Axis Mechanism.

Authors:  Xiaohui Sun; Li Xue; Zechen Wang; Anmu Xie
Journal:  Front Neurosci       Date:  2022-07-06       Impact factor: 5.152

Review 5.  Mechanistic Insights Expatiating the Redox-Active-Metal-Mediated Neuronal Degeneration in Parkinson's Disease.

Authors:  Tapan Behl; Piyush Madaan; Aayush Sehgal; Sukhbir Singh; Md Khalid Anwer; Hafiz A Makeen; Mohammed Albratty; Syam Mohan; Simona Bungau
Journal:  Int J Mol Sci       Date:  2022-01-08       Impact factor: 5.923
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.